VOYA Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

VOYA Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.1M	Sell	64,042 -4,525	-7%	-$791K	0.01%	568
2025 Q4	$11.7M	Buy	68,567 +458	+0.7%	+$70.2K	0.01%	614
2025 Q3	$8.98M	Buy	68,109 +1,403	+2%	+$168K	0.01%	690
2025 Q2	$7.08M	Buy	66,706 +10,357	+18%	+$1.13M	0.01%	841
2025 Q1	$7M	Buy	56,349 +22,628	+67%	+$2.95M	0.01%	838
2024 Q4	$4.15M	Sell	33,721 -1,835	-5%	-$216K	﹤0.01%	1042
2024 Q3	$3.96M	Sell	35,556 -1,651	-4%	-$181K	﹤0.01%	1096
2024 Q2	$3.97M	Sell	37,207 -7,775	-17%	-$855K	﹤0.01%	1087
2024 Q1	$5.42M	Sell	44,982 -12,352	-22%	-$1.51M	0.01%	967
2023 Q4	$7.05M	Sell	57,334 -506	-0.9%	-$63.1K	0.01%	861
2023 Q3	$7.49M	Sell	57,840 -1,873	-3%	-$250K	0.01%	813
2023 Q2	$7.4M	Sell	59,713 -2,655	-4%	-$357K	0.01%	845
2023 Q1	$9.13M	Buy	62,368 +12,962	+26%	+$1.92M	0.01%	762
2022 Q4	$7.87M	Sell	49,406 -16,945	-26%	-$2.48M	0.01%	809
2022 Q3	$8.84M	Buy	66,351 +30,264	+84%	+$4.6M	0.01%	753
2022 Q2	$5.63M	Buy	36,087 +1,611	+5%	+$248K	0.01%	696
2022 Q1	$5.37M	Sell	34,476 -637	-2%	-$92.4K	0.01%	818
2021 Q4	$4.47M	Sell	35,113 -10,865	-24%	-$1.43M	0.01%	882
2021 Q3	$5.99M	Sell	45,978 -1,072	-2%	-$162K	0.01%	782
2021 Q2	$8.36M	Buy	47,050 +622	+1%	+$108K	0.02%	676
2021 Q1	$7.63M	Sell	46,428 -45	-0.1%	-$7.41K	0.02%	683
2020 Q4	$7.67M	Buy	46,473 +14,006	+43%	+$2.09M	0.02%	667
2020 Q3	$4.63M	Buy	32,467 +22,403	+223%	+$2.78M	0.01%	776
2020 Q2	$1.11M	Sell	10,064 -9,371	-48%	-$1.04M	﹤0.01%	1226
2020 Q1	$1.94M	Sell	19,435 -422	-2%	-$54.6K	0.01%	960
2019 Q4	$2.96M	Buy	19,857 +5,073	+34%	+$690K	0.01%	962
2019 Q3	$1.89M	Buy	14,784 +67	+0.5%	+$8.98K	﹤0.01%	1048
2019 Q2	$2.1M	Sell	14,717 -1,979	-12%	-$266K	﹤0.01%	1036
2019 Q1	$2.39M	Sell	16,696 -513,891	-97%	-$67M	0.01%	999
2018 Q4	$65.8M	Buy	530,587 +49,998	+10%	+$7.42M	0.16%	135
2018 Q3	$80.8M	Buy	480,589 +73,069	+18%	+$12.6M	0.17%	134
2018 Q2	$70.2M	Buy	+407,520	New	+$66.6M	0.15%	153
2016 Q2	–	Sell	-26,264	Closed	-$3.43M	–	2576
2016 Q1	$3.43M	Sell	26,264 -660	-2%	-$82.2K	0.01%	856
2015 Q4	$3.78M	Sell	26,924 -793	-3%	-$110K	0.01%	838
2015 Q3	$3.68M	Sell	27,717 -357	-1%	-$61.5K	0.01%	843
2015 Q2	$4.94M	Sell	28,074 -301	-1%	-$54.1K	0.01%	791
2015 Q1	$4.9M	Sell	28,375 -68	-0.2%	-$11.7K	0.01%	811
2014 Q4	$4.66M	Sell	28,443 -1,484	-5%	-$246K	0.01%	824
2014 Q3	$4.8M	Sell	29,927 -296	-1%	-$45.5K	0.01%	803
2014 Q2	$4.44M	Buy	30,223 +3,410	+13%	+$473K	0.01%	856
2014 Q1	$3.72M	Buy	26,813 +31	+0.1%	+$4.67K	0.01%	880
2013 Q4	$3.39M	Sell	26,782 -483	-2%	-$50K	0.01%	904
2013 Q3	$2.51M	Sell	27,265 -60	-0.2%	-$4.84K	0.01%	1004
2013 Q2	$1.88M	Buy	+27,325	New	+$1.67M	0.01%	1086

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

VOYA Investment Management's JAZZ Position: Q1 2026 in Review

VOYA Investment Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 6.6% in Q1 2026, selling an estimated $791K and leaving 64,042 shares worth $12.1M. The position accounts for 0.01% of the portfolio, ranked #568.

VOYA Investment Management first reported a position in JAZZ in Q2 2013 and has held it in 44 quarters since. The position peaked at $80.8M in Q3 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

VOYA Investment Management held 64,042 shares of Jazz Pharmaceuticals worth $12.1M as of Q1 2026.
VOYA Investment Management sold 4,525 Jazz Pharmaceuticals shares in Q1 2026, an estimated $791K.
Jazz Pharmaceuticals made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #568 holding.
VOYA Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
VOYA Investment Management's Jazz Pharmaceuticals position peaked at $80.8M in Q3 2018.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.